Introduction
============

For anthropocentric reasons, bacteria are often conceptually divided into free-living and host-associated organisms. However, we know that different members of the same bacterial phylum can exhibit a multitude of lifestyles (free-living, pathogen, symbiont), and even that a single species can engage in different kinds of relationships with different hosts. It is also clear that bacterial phyla containing known pathogens and symbionts are enormously over-represented in our culture collections and sequence databases (Martiny and Field, [@B21]), whereas our knowledge of many novel phyla is limited to a handful of strains. The relatively obscure bacterium *Verrucomicrobium spinosum* (phylum Verrucomicrobia) was isolated from a lake in northern Germany (Schlesner, [@B28]), and its most interesting feature until now has been its unusual cellular morphology, featuring wart-like cellular protrusions (Schlesner, [@B28]) and a compartmentalized cell plan shared with the planctomycetes (Lee et al., [@B17]). For two decades, *V. spinosum* has been regarded as a free-living, non-pathogenic microbe, but its genome sequence contains a predicted Type III secretion system (T3SS; Pallen et al., [@B22]). T3SS is a hallmark of bacteria--eukaryote interactions, chiefly known for its role as a pathogenesis factor, delivering toxic effector proteins via direct cell-to-cell contact with eukaryotic cells, but also involved in symbioses (Galán and Wolf-Watz, [@B9]). It has been suggested that "free-living" organisms possessing predicted T3SS may participate in uncharacterized interactions with eukaryotes (Pallen et al., [@B22]). Our study aimed to test this hypothesis on *Verrucomicrobium spinosum* and to begin characterization of its predicted T3SS. We achieved our aims by generating experimental data on the transcriptional activity and protein--protein interactions of T3SS genes and their gene products, respectively. We also demonstrated that *V. spinosum* can kill two different model invertebrate hosts.

Results
=======

*V. spinosum* possesses and expresses predicted type III secretion system genes
-------------------------------------------------------------------------------

The *V. spinosum* genome contains all required structural components for a functional T3SS (Figure [1](#F1){ref-type="fig"}; Table [A1](#TA1){ref-type="table"} in Appendix). The *V. spinosum* T3SS genes are found in a cluster with strikingly similar organization to other T3SS gene clusters, particularly the well-characterized T3SS found in *Yersinia* species, and the T3SS of desulfovibrios and related organisms (Heidelberg et al., [@B14]; Pallen et al., [@B22]). All essential categories of T3SS structural proteins were identified, including membrane anchors (VspC, VspQ), candidate needle proteins (VspF1, VspF2), needle protein chaperones (VspE, VspG), and an ATPase (VspN; Table [A1](#TA1){ref-type="table"} in Appendix). Importantly, we found that several of these genes were actively transcribed. Transcription of predicted outer and inner bacterial membrane anchors of the T3SS, and candidate needle proteins, was detected by RT-PCR (Figure [2](#F2){ref-type="fig"}) under standard growth conditions (described in Materials and Methods). Furthermore, specialized cytoplasmic chaperones are usually required for the stability of the T3SS, and the efficient translocation of T3SS components and effectors (Galán and Wolf-Watz, [@B9]). We demonstrated a physical association between one needle protein (VspF1) and one chaperone (VspE; Table [A2](#TA2){ref-type="table"} in Appendix) by yeast two-hybrid screening, thus supporting a functional interaction.

![***Verrucomicrobium spinosum* possesses genes predicted to encode a T3SS**. **(A)** General organization of T3SS structural components in experimentally characterized T3SS, labeled according to the *Yersinia* T3SS nomenclature. **(B)** Organization of predicted T3SS structural genes in the genomes of *V. spinosum*, *Desulfovibrio vulgaris*, *Lawsonia intracellularis*, and *Chlamydophila pneumoniae*. The latter is included because the chlamydiae are generally considered to be more phylogenetically related to the Verrucomicrobia than other phyla. Genes are colored to correspond to the protein components depicted in part **(A)** of the figure. Double vertical lines indicate that the T3SS genes are not immediately adjacent to each other in the respective genomes.](fmicb-02-00211-g001){#F1}

![**Detection of VspC, VspQ, VspF1, and VspF2 expression by RT-PCR**. Lane 1: *V. spinosum* RNA in the presence of reverse transcriptase and DNA polymerase; Lane 2: water (PCR negative control); Lane 3: *V. spinosum* RNA in the absence of reverse transcriptase and presence of DNA polymerase; Lane 4: *V. spinosum* DNA in the absence of reverse transcriptase and presence of DNA polymerase.](fmicb-02-00211-g002){#F2}

Expression of predicted *V. spinosum* T3SS effector proteins suppresses growth of yeast
---------------------------------------------------------------------------------------

We next used a yeast functional screen (Lesser and Miller, [@B19]) to experimentally confirm the toxicity of predicted T3SS effector proteins from *V. spinosum*. Expression of T3SS effectors, but not other bacterial proteins, causes growth inhibition of *Saccharomyces cerevisiae* (Lesser and Miller, [@B19]; Slagowski et al., [@B30]). We identified three candidate effectors, based on their proximity to the T3SS structural gene cluster, sequence similarity to known T3SS effectors, and/or sequence properties reported to be characteristic of T3SS effectors (Schechter et al., [@B27]). Two of these, open reading frame (ORF) 05930 (*p* = 7.9 e 10^−17^; *t*-test) and ORF04374 (*p* = 3.3 e 10^−7^; *t*-test), showed a significant inhibition of growth under inducing conditions (Figure [3](#F3){ref-type="fig"}). Expression of control *V. spinosum* genes showed no such effect. While we have not directly demonstrated that the predicted T3SS secretes these predicted effectors, our data suggest that injection of these effectors into eukaryotic cells would be toxic, similar to other known T3SS effectors.

![**Optical density of yeast cultures expressing putative effector genes (on right) and negative control genes (on left)**. Vertical bar represents distribution of values for 12 individual clones repeated in duplicate. \**p* = 7.9 e^−17^ (ORF05930, *t*-test) and 3.3 e10^−7^ (ORF04374, *t*-test).](fmicb-02-00211-g003){#F3}

*V. spinosum* increases mortality of *D. melanogaster*
------------------------------------------------------

We next performed standard infection assays (Schneider et al., [@B29]) with *V. spinosum* in *Drosophila melanogaster*. *Drosophila* is an established model organism for examining T3SS-mediated pathogenesis (Brandt et al., [@B4]). Although non-pathogenic bacteria can elicit an immune response when injected into *D. melanogaster* (Lemaitre et al., [@B18]), they have no effect on fly mortality (Schneider et al., [@B29]). Wild-type (Oregon R) flies infected with *V. spinosum* died more quickly than flies injected with buffer alone (Figure [4](#F4){ref-type="fig"}), with approximately 40% survival after 20 days, compared to 85% survival for negative control buffer-injected flies (*p* = \<1.0 × 10^−4^). A similar effect observed using wild-type *Salmonella typhimurium* was shown to be dependent on the T3SS (Brandt et al., [@B4]).

![***Drosophila melanogaster* survival assays for *V. spinosum* (squares) and PBS negative control (diamonds)**. Each experiment comprised 100 male wild-type Oregon R flies. Infected flies died faster than control flies according to log-rank analysis (*p* \< 0.0001).](fmicb-02-00211-g004){#F4}

*V. spinosum* increases mortality of *C. elegans*
-------------------------------------------------

We also examined the effect of *V. spinosum* exposure on the mortality of *Caenorhabditis elegans*. Sterile mutant worms \[*fer-15(b26);* *fem-1(hc17)*\] exposed to living *V. spinosum* exhibited increased mortality relative to control worms feeding on *Escherichia coli* (Figure [5](#F5){ref-type="fig"}A), whereas heat-killed *V. spinosum* cells had no such effect (Figure [A1](#FA1){ref-type="fig"}A in Appendix). This suggested a direct and adverse interaction between living *V. spinosum* and the worm rather than a non-specific mortality increase due to provision of a nutritionally inferior diet or similar non-specific effect. *V. spinosum*-induced mortality was increased (Figure [5](#F5){ref-type="fig"}B) in a worm deletion mutant \[*fshr-1(ok778)*\] previously shown to be hypersensitive to pathogen infection by multiple agents (Powell et al., [@B25]). Using a multi-copy extrachromosomal array that overexpresses *fshr-1* (Cho et al., [@B5]), we were able to completely reverse *V. spinosum*-associated death in *fshr-1(ok778)* mutants (Figure [5](#F5){ref-type="fig"}B). In fact, overexpression of *fshr-1* substantially reduced mortality of *fshr-1(ok778)* mutants exposed to *V. spinosum* to levels below that observed for wild-type, similar to our observations with the known pathogens, *S. aureus*, and *E. faecalis* (Figures [A1](#FA1){ref-type="fig"}B,C in Appendix). In contrast, *fshr-1* expression levels do not correlate to life expectancy on a non-pathogenic strain (Figure [A1](#FA1){ref-type="fig"}D in Appendix), indicating that the effects of *fshr-1* on survival are specific to pathogen exposure (Powell et al., [@B25]).

![***Caenorhabditis elegans* survival assays**. Each experiment comprised of approximately 100 worms. **(A)** CF512 worms (sterile mutants) exposed to *E. faecalis* and *V. spinosum* died faster than CF512 worms exposed to *E. coli*, according to log-rank analysis (*p* = 0 for *E. faecalis* and 2.33e^−15^ for *V. spinosum*). **(B)** When exposed to *V. spinosum*, worm mutants hypersensitive to pathogens (*fshr-1*) died faster than N2 wild-type worms (*p* = 5.04 e^−7^). Worms over-expressing an *fshr-1* multi-copy array died more slowly than N2 wild-type worms (*p* = 7.18 e^−13^).](fmicb-02-00211-g005){#F5}

Can we predict the natural eukaryotic host of *V. spinosum*?
------------------------------------------------------------

Phylogenetic analysis of structural T3SS proteins has shown most bacteria possessing T3SS to cluster according to their specific interaction type, such as plant pathogen, obligate intracellular animal pathogen, or extracellular animal pathogen (Troisfontaines and Cornelis, [@B33]). In an attempt to predict the nature of any uncharacterized *V. spinosum*--eukaryote interaction, we conducted phylogenetic analysis of YscN-like sequences (the T3SS ATPase from *Yersinia*) from *V. spinosum*, all available free-living bacteria carrying predicted T3SS genes, and reference pathogens and symbionts (Figure [6](#F6){ref-type="fig"}). The *V. spinosum* YscN appeared most closely related to those from strains of three deltaproteobacteria: *Lawsonia intracellularis*, *Desulfovibrio piger* and *Desulfovibrio vulgaris*. This cluster was recovered with analysis of some, but not all, additional T3SS genes (data not shown). *L. intracellularis* is an obligate intracellular pathogen and causes proliferative enteritis in pigs (Kroll et al., [@B16]). Members of the genus *Desulfovibrio* are anaerobic sulfate-reducing bacteria and include both commensals and pathogens of the human gastrointestinal tract (Gibson et al., [@B11], [@B10]; Willis et al., [@B37]; Zinkevich and Beech, [@B38]; Loubinoux et al., [@B20]; Goldstein et al., [@B12]), as well as free-living environmental bacteria. Specifically, strains of *D. piger* and *D. vulgaris* are human intestinal commensals and *D. piger* also acts as an occasional human opportunistic pathogen. Genes predicted to encode T3SS in the *L. intracellularis* and *D. vulgaris* genomes have been described previously (Heidelberg et al., [@B14]; Pallen et al., [@B22]), and the T3SS of *L. intracellularis* has recently been linked to pathogenesis in the porcine host (Alberdi et al., [@B2]). There are no reports of infection of invertebrate models with these organisms, so it is not clear whether their host range could extend to invertebrates.

![**Phylogenetic relationship of T3SS ATPases from *V. spinosum* and representatives of other bacterial groups containing T3SS; the ATPase group associated with the flagellar apparatus was used as an outgroup**. Bootstrap values obtained based on 1000 bootstrap runs are indicated by: O above 80%, Δ between 80 and 60%; values less than 60% are not shown. Bar denotes 0.3 amino acid substitutions per site. Collapsed clades indicate T3SS classes as described by Troisfontaines and Cornelis ([@B33]). Hrc1 and Hrc2 plant pathogen groups; intracellular survival; invasive phenotype; *Chlamydiales* T3SS family (intracellular life-style); extracellular pathogen life-style, resistance to phagocytosis, and triggering of apoptosis in macrophages; *Rhizobiales* T3SS family (symbiotic relations with leguminous plants). Open clusters contain at least one "free-living" organism.](fmicb-02-00211-g006){#F6}

Discussion
==========

We have begun to address two questions, using *Verrucomicrobium spinosum* as a test case. The first question is whether predicted T3SS genes without established function in "free-living" bacteria have the potential to encode a functional T3SS, i.e., an injectisome that translocates effector proteins into a eukaryotic host cell. Our results showed that the predicted T3SS genes of *V. spinosum* are transcriptionally active and identify a candidate chaperone for one of two predicted T3SS needle proteins. We also demonstrated that expression of *V. spinosum* proteins inhibits growth in an established yeast functional screen for T3SS effectors. Although the growth inhibition appears modest (Figure [3](#F3){ref-type="fig"}), use of this screen with characterized virulence proteins from a known pathogen (*Shigella flexneri*) showed that growth inhibition was variable (up to 50% compared to controls; Slagowski et al., [@B30]). Thus the 50% growth inhibition observed for *V. spinosum* ORF05930 corresponded to the most toxic protein screen result from *S. flexneri*. These findings represent only first steps toward characterizing the putative *V. spinosum* T3SS. Future work includes determining whether T3SS genes are expressed at the protein level, whether the resulting proteins assemble to form an injectisome, and whether the injectisome translocates the predicted effectors into a host cell. It will also be necessary to pursue approaches complementary to yeast two-hybrid screens to characterize chaperone interactions, as it is possible that the very nature of chaperones leads them to interact non-specifically with poorly folded proteins.

The second question is whether *V. spinosum* can interact with eukaryotes. The results of our infection studies in two different model invertebrates suggest that it can. In particular, the increased mortality of *C. elegans* *fshr-1* deletion mutants exposed to *V. spinosum*, relative to wild-type worms, strongly argues for a pathogenic interaction in this model. However, we cannot presently extrapolate this result to the natural host(s) of *V. spinosum*, given that mechanisms of bacterial pathogenesis (e.g., T3SS) are also used to initiate and maintain symbiotic relationships (Viprey et al., [@B35]), and that a given bacterium can engage in pathogenic and symbiotic interactions with different hosts (Preston, [@B26]). A symbiotic relationship also appears plausible given the known symbiotic associations of other verrucomicrobial species, such as *Candidatus* *Xiphinematobacter* with nematodes (Vandekerckhove et al., [@B34]), and the verrucomicrobial ectosymbiont that defends its ciliate host from predation (Petroni et al., [@B23]). In addition, a verrucomicrobial species occurs as a dominant member of the mucin-degrading bacterial population of the human intestine (Derrien et al., [@B6]). Future work includes determining the natural host range of *V. spinosum*, and the nature and route of the host interaction. This is a challenging goal given the many possible host taxa. However, our phylogenetic analysis of the *V. spinosum* T3SS proteins suggests that they are related to those found within *Desulfovibrio* and relatives, a group that includes known intestinal pathogens of vertebrates, as well as free-living strains. This suggests a number of possible avenues: to test vertebrate hosts for susceptibility to *V. spinosum* infection, and to test ingestion as an infection route in both vertebrate and invertebrate hosts. Interestingly, the role of FSHR-1 in pathogen defense in *C. elegans* is specific to the intestinal tract (Powell et al., [@B25]), consistent with *V. spinosum* acting through this tissue.

Another obvious goal is determination of the role of the predicted *V. spinosum* T3SS in the mortality observed in invertebrate infection models. The major hurdle to this work is that the development of genetic tools for *V. spinosum* is still in its infancy. Although a method for random transposon mutagenesis of the *V. spinosum* genome has been recently described (Domman et al., [@B7]), work is still underway to increase transformation efficiency so that mutant libraries of adequate size can be generated. In addition, neither transformation of *V. spinosum* cells with plasmid DNA nor targeted knock-out of specific genes via transposon mutagenesis has yet been achieved. With further progress in development of genetic tools for *V. spinosum*, it should also be possible to generate tagged *V. spinosum* mutants useful for fulfilling Koch's postulates (i.e., recovering the presumed pathogen/symbiont from the host) and determining whether the organism colonizes host tissue in the invertebrate infection models. In the absence of a selectable marker or fluorescent tag, it has proven difficult to quantify *V. spinosum* in worm or fly tissue due to overgrowth with normal fly/worm flora on artificial culture media. This question could also be pursued with FISH probing of host tissues with a *V. spinosum*-specific probe. An alternative, or complementary approach, to determining whether the putative *V. spinosum* T3SS is responsible for the observed invertebrate mortality would be to test for up-regulation of the relevant genes in the *D. melanogaster* or *C. elegans* infection models.

With the rapid development of sequencing technology, bacterial genome sequencing has revealed predicted pathogenesis/symbiosis determinants in several organisms not previously known to interact with eukaryotes (Pallen et al., [@B22]). Further examination of unpublished but publicly available genome sequences reveals the presence of such determinants in multiple other "free-living" genomes (<http://img.jgi.doe.gov/cgi-bin/pub/main.cgi>). Here we map out a general methodology moving from bioinformatics to experimental analysis, taking advantage of established eukaryotic models from yeast to flies and worms to test the potential eukaryotic interactions of bacterial strains.

Materials and Methods
=====================

Bioinformatic predictions and phylogenetic analysis
---------------------------------------------------

The *V. spinosum* genome sequence (accession ABIZ00000000) and the sequences of reference genomes were obtained from GenBank. Protein structure was predicted using the Phyre server (Kelley and Sternberg, [@B15]). Protein sequences of the T3SS ATPase (YscN) were identified using BLASTP (Altschul et al., [@B3]). The ATP synthase of *E. coli* associated with the flagellar apparatus was included in the analysis as an outgroup. Protein sequences were aligned using MUSCLE (Edgar, [@B8]) with default parameters. The WAG + I + GAMMA model (Whelan and Goldman, [@B36]) was determined as the model of best fit \[according to AIC (Sugiura, [@B32])\] using the ProtTest tool (Abascal et al., [@B1]) with default parameters. Maximum likelihood phylogeny was obtained using PhyML software (Guindon and Gascuel, [@B13]) implementing the WAG + I + GAMMA evolutionary model, with 1000 bootstrap runs.

Bacterial strains and cultivation conditions
--------------------------------------------

*Verrucomicrobium spinosum* type strain DSM 4136 was grown in liquid M13 medium (Schlesner, [@B28]) incubated statically at 30°C for 72 h.

RNA isolation and RT-PCR
------------------------

Ten milliliters of *V. spinosum* culture was collected by centrifugation and frozen at −80°C for 5 min. Cells were thawed, 250 μl TriZol reagent was added, and RNA isolation performed as recommended by the manufacturer. Pellets were re-suspended and incubated for 15 min at 55°C in 100 μl RNase-free water, DNase-treated, and subsequently passed through an RNeasy mini kit (Qiagen) according to the manufacturer's instructions. Reverse transcription was performed using the iScript cDNA synthesis kit (Bio-rad) according to the manufacturer's instructions. PCR targeting VspC (ORF05910), VspQ (ORF05897), VspF1 (ORF05907), and VspF2 (ORF05908) was performed using *V. spinosum* cDNA or gDNA as the nucleic acid template. Reaction mixtures consisted of 1 × PCR buffer (NEB), 1.5 mM MgCl~2~, 10 μM each primer (Table [A3](#TA3){ref-type="table"} in Appendix), 200 μM each dNTP, 0.2 U Taq DNA polymerase, 30 ng of cDNA in a 50-μl volume. Reaction conditions consisted of an initial denaturation step of 95°C for 3 min followed by 35 repeat cycles of 95°C for 10 s, 62°C for 10 s, and 72°C for 20 s, and a single final extension step at 72°C for 5 min.

Yeast two-hybrid screens
------------------------

Open reading frames were PCR-amplified from *V. spinosum* genomic DNA (gDNA). PCR was performed in a mixture of 1 × iProof High-Fidelity DNA polymerase PCR reaction mix (Bio-Rad), 25 μM each primer, and approximately 30 ng of *V. spinosum* gDNA in a final volume of 50 μl. Reaction conditions consisted of an initial denaturation step of 98°C for 30 s followed by 30 cycles of 98°C for 10 s, 54--60°C (see Table [A3](#TA3){ref-type="table"} in Appendix for primer sequences and annealing temperatures) for 10 s and 72°C for 1 min, followed by a single final extension step of 72°C for 5 min. PCR products were gel-purified using a QIAquick gel extraction kit (Qiagen), and cloned into pENTR/SD/D-TOPO (Invitrogen). *E. coli* NEB5α chemically competent cells (NEB) were transformed with the resulting constructs to generate entry clones. Correct sequence and orientation of each ORF was confirmed by DNA sequencing of entry clones. ORF's were transferred to pDEST22 (Prey) and pDEST32 (Bait) vectors (Invitrogen) by LR recombination and specific protein--protein interactions were tested using the ProQuest Two-Hybrid System (Invitrogen), according to the manufacturer's instructions.

Yeast T3SS effector screen
--------------------------

Putative T3SS effectors were selected for yeast genetic screening (Lesser and Miller, [@B19]) if they showed high BLASTP similarity to known T3SS effectors in other organisms, or if they yielded high scores in criteria for T3SS effectors described previously (Schechter et al., [@B27]). PCR primers were designed to incorporate a yeast translation initiation sequence at the 5′ end of the ORF and the stop codon was removed to allow fusion with a V5 epitope and polyhistidine tag. Putative T3SS effectors (ORF01842, ORF04374, ORF05930) and controls (ORF03840, ORF04373, ORF05921) were amplified by PCR. PCR contained 1 × ReadyMix PCR reaction mix (Sigma), 25 μM each primer (Table [A3](#TA3){ref-type="table"} in Appendix), 30 ng *V. spinosum* gDNA, 3% (v/v) DMSO, 1.5 mM MgCl~2~, and reaction conditions consisted of an initial denaturation step of 94°C for 5 min, followed by 35 cycles of 94°C for 15 s, 56°C for 15 s and 72°C for 1 min, and a single final extension step at 72°C for 5 min. PCR products were gel-purified using a QIAquick gel extraction kit (Qiagen), cloned into pYES2.1 TOPO (Invitrogen). *E. coli* TOP10 chemically competent cells (Invitrogen) were transformed with the resulting constructs according to the manufacturer's instructions. Correct sequence and orientation of each ORF was confirmed by DNA sequencing. Plasmids were extracted from 5 ml *E. coli* TOP10 using the QiaQuick plasmid miniprep kit (Qiagen). *S. cerevisiae* str. InvSc1 (Invitrogen) was transformed with approximately 1 μg plasmid mixed with 100 μg salmon sperm DNA, using a lithium acetate transformation protocol described by the manufacturer. Resulting transformants containing expression plasmids were selected by growth on SM-Ura media.

*Saccharomyces cerevisiae* InvSc1 clones containing expression plasmids were grown in 5 ml non-inducing media (SM-ura + glucose) until culture had an OD~600~ of approximately 1.0. Cultures were normalized and inoculated into induction media (SM-ura + galactose) so that an OD~600~ of 0.05 was obtained. Tubes were incubated for 48 h at 30°C and the OD~600~ recorded. The final OD~600~ recorded was the average of two replicate cultures of 12 individual clones for each putative T3SS effector or control.

Fly experiments
---------------

Survival assays in *D. melanogaster* were performed as previously described (Schneider et al., [@B29]). 60--100 wild-type male Oregon R flies were assayed per condition. Flies were infected with either *V. spinosum* \[concentrated in phosphate-buffered saline (PBS) to an OD~600~ of 1.0\] or PBS alone and incubated at 29°C. Death was recorded daily. Survival curves are plotted as Kaplan--Meier plots and statistical significance tested using log-rank analysis using GraphPad Prism software. All experiments were performed at least three times and yielded similar results.

Worm experiments
----------------

Strains were maintained according to standard procedures (Stiernagle, [@B31]) and cultured at 20°C, with the exception of experiments conducted with CF512; such experiments were performed at 25°C. Strains used or generated included the following: N2, wild-type; CF512, \[*fer-15(b26);* *fem-1(hc17)*\]; WY346, \[*fshr-1(ok778)*\]; WY335, \[*fshr-1(ok778); fdEx41*\] (this multi-copy extrachromosomal array contains the wild-type *fshr-1* locus as well as a *sur-5*::GFP marker; Cho et al., [@B5]). Bacterial killing assays were performed at 20°C, unless otherwise noted, as previously described (Powell and Ausubel, [@B24]). *V. spinosum* was cultivated in liquid M13 medium as described above, while *E. coli*, *S. aureus*, and *E. faecalis* were cultivated in tryptic soy broth at 37°C. After concentration of bacterial cultures by centrifugation, all bacterial strains were applied to NGM plates (Stiernagle, [@B31]) for the killing assays. Log-rank analysis was used to calculate mean survival for each population of worms, using the online server at <http://bioinf.wehi.edu.au/software/russell/logrank/>. Each population (biological replicate) was an average of two or three independent plates containing 50 worms each. Figures show data from representative biological replicates.
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**Type III Secretion System structural genes and chaperones in the *V. spinosum* genome, predicted on the basis of primary sequence similarity (BLASTP comparison) and domain structure**.

  Open reading frame   Description                                                             Top BLASTP match                                                                                                                                                                                                                                                  Required for type III secretion?
  -------------------- ----------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------
  ORF02659             Type III secretion chaperone DspF family                                ZP_02197308.1 *Vibrio campbellii* AND4 hypothetical protein \[Identities = 38/136 (27%), Positives = 57/136 (41%), Gaps = 0/136 (0%)\] (4e-06)                                                                                                                    No
  ORF02982             Type III secretion chaperone CesT family                                YP_002436649.1 *Desulfovibrio vulgaris* str. "Miyazaki F" Tir chaperone family protein \[Identities = 41/138 (29%), Positives = 59/138 (42%), Gaps = 3/138 (2%)\] (2e-08)                                                                                         No
  ORF03096             Type III secretion chaperone CesT family                                YP_002436233.1 *Desulfovibrio vulgaris* str. "Miyazaki F" Tir chaperone family \[Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 7/139 (5%)\] (5e-07)                                                                                                 No
  ORF03208             Type III secretion chaperone, CesT family                               ZP_03311875.1 *Desulfovibrio piger* ATCC 29098 hypothetical protein \[Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 4/119 (3%)\] (5e-05)                                                                                                            No
  ORF04373             Type III secretion chaperone CesT family                                YP_002680810.1 *Pseudovibrio* sp. JE062 type III secretion chaperone, CesT family \[Identities = 33/123 (26%), Positives = 50/123 (40%), Gaps = 8/123 (6%)\] (0.081)                                                                                              No
  ORF04377             Type III secretion chaperone CesT family                                YP_002680810.1 *Pseudovibrio* sp. JE062 type III secretion chaperone, CesT family \[Identities = 40/144 (27%), Positives = 57/144 (39%), Gaps = 7/144 (4%)\] (0.007)                                                                                              No
  ORF04807             Type III secretion chaperone CesT family                                gb\|AAY36239.1\| *Pseudomonas syringae pv. syringae* B728a type III chaperone protein ShcM \[Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 9/111 (8%)\] (0.002)                                                                                     No
  ORF05889             Type III secretion chaperone CesT family                                ZP_02197308.1 *Vibrio campbellii* AND4 hypothetical protein AND4_08621 \[Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 0/129 (0%)\] (5e-10)                                                                                                         No
  ORF05893             Type III secretion protein YscU/HrpY                                    ZP_01259729.1 *Vibrio alginolyticus* translocation protein in type III secretion \[Identities = 155/339 (45%), Positives = 237/339 (69%), Gaps = 0/339 (0%; 9e-97)                                                                                                Yes
  ORF05894             Type III secretion protein SpaR/YscT/HrcT                               NP_798053.1 *Vibrio parahaemolyticus* type III secretion apparatus protein SpaR/YscT/HrcT \[Identities = 106/237 (44%), Positives = 155/237 (65%), Gaps = 3/237 (1%)\] (6e-50)                                                                                    Yes
  ORF05895             Type III secretion protein HrpO family (YscS/HrcS/SctS/EscS)            ZP_01550017.1 *Stappia aggregata* Type III secretory pathway, component EscS \[Identities = 48/89 (53%), Positives = 67/89 (75%), Gaps = 0/89 (0%)\] (2e-20)                                                                                                      Yes
  ORF05896             Type III secretion apparatus protein YscR/HrcR                          ZP_02195905.1 *Vibrio campbellii* translocation protein in type III secretion \[Identities = 133/215 (61%), Positives = 170/215 (79%), Gaps = 0/215 (0%)\] (4e-70)                                                                                                Yes
  ORF05897             Type III secretion apparatus protein YscQ/HrcQ/SpaO                     YP_001444923.1 *Vibrio harveyi* ATCC BAA-1116 type III secretion system protein \[Identities = 86/293 (29%), Positives = 131/293 (44%), Gaps = 25/293 (8%)\] (1e-15)                                                                                              Yes
  ORF05898             Putative T3SS needle length determinant                                 YP_436215.1 *Hahella chejuensis* KCTC 2396 hypothetical protein HCH_05109 \[Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 5/88 (5%)\] (4e-05)                                                                                                         No
  ORF05899             Type III secretion protein O                                            ABM29998.1 *Desulfovibrio vulgaris* spp. *vulgaris* DP4 type III secretion YscO family protein \[Identities = 57/155 (36%), Positives = 88/155 (56%), Gaps = 0/155 (0%)\] (8e-11)                                                                                 No
  ORF05900             Type III secretion apparatus H +  transporting two-sector ATPase YscN   YP_594915.1 *Lawsonia intracellularis* PHE/MN1-00 type III secretion system ATPase \[Identities = 307/435 (70%), Positives = 357/435 (82%), Gaps = 0/435 (0%)\](4e-179)                                                                                           Yes
  ORF05901             Type III secretion apparatus protein HrpE/YscL family                   AAO18079.1 *Photorhabdus luminescens* LscL \[Identities = 65/200 (32%), Positives = 118/200 (59%), Gaps = 11/200 (5%)\] (1e-26)                                                                                                                                   Yes
  ORF05904             Type III secretion apparatus lipoprotein YscJ/HrcJ                      ZP_01769285.1 *Burkholderiapseudomallei* 305 type III secretion apparatus lipoprotein, YscJ/HrcJ family \[Identities = 101/245 (41%), Positives = 143/245 (58%), Gaps = 17/245 (6%)\] (5e-44)                                                                     Yes
  ORF05909             Type III secretion apparatus protein YscD/HrpQ family                   ABC30002.1 *Hahella chejuensis* KCTC 2396 putative type III export protein YscD \[Length = 446 Identities = 83/330 (25%), Positives = 145/330 (43%), Gaps = 24/330 (7%)\] (2e-15)                                                                                 Yes
  ORF05910             Type III secretion outer membrane pore YscC/HrcC family                 YP_434425.1 *Hahella chejuensis* KCTC 2396 putative type III secretion \[Identities = 179/568 (31%), Positives = 295/568 (51%), Gaps = 40/568 (7%)\] (5e-69)                                                                                                      Yes
  ORF05911             Type III secretion chaperone CesT family                                YP_961197.1 *Desulfovibrio vulgaris* spp. *vulgaris* DP4 TIR chaperone family protein \[Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 13/127 (10%)\](2.9)                                                                                           No
  ORF05912             Type III secretion protein LcrD/AscV/YscV                               NP_863517.1 *Yersinia enterocolitica* LcrD \[Identities = 388/692 (56%), Positives = 537/692 (77%), Gaps = 17/692 (2%)\] (0.0)                                                                                                                                    Yes
  ORF05915             Type III secretion chaperone SycN family                                ZP_01259739.1 *Vibrio alginolyticus* 12G01 putative type III secretion protein \[Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 5/123 (4%)\] (2e-04)                                                                                                 No
  ORF05917             Type III secretion regulator YopN/LcrE/InvE/MxiC                        YP_961203.1 *Desulfovibrio vulgaris* spp. *vulgaris* DP4 type III secretion regulator YopN/LcrE/InvE/MxiC \[Identities = 93/246 (37%), Positives = 136/246 (55%), Gaps = 18/246 (7%)\] (2e-28)                                                                    No
  ORF05919             Putative Type III secretion system protein EscC                         YP_002932398.1 *Edwardsiella ictaluri* 93-146 EscC \[Identities = 89/356 (25%), Positives = 154/356 (43%), Gaps = 70/356 (19%)\] (3e-08)                                                                                                                          No
  ORF05921             Type III secretion low calcium response chaperone LcrH/SycD/SpaT        ZP_01985138.1 *Vibrioharveyi* HY01 type III secretion low calcium response chaperone LcrH/SycD \[Identities = 52/149 (34%), Positives = 91/149 (61%), Gaps = 0/149 (0%)\] (4e-21)                                                                                 No
  ORF05929             Type III secretion chaperone CesT family                                YP_001906486.1 *Erwiniatasmaniensis* Et1/99 Potential ORFB-specific chaperone, encodes a homolog of virulence/avirulence effector proteins secreted via the type III pathway \[Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 3/107 (2%)\] (1e-08)   No
  ORF05931             Type III secretion chaperone CesT family                                YP_002680810.1 *Pseudovibrio* sp. JE062 type III secretion chaperone, CesT family \[Identities = 31/124 (25%), Positives = 59/124 (47%), Gaps = 2/124 (1%)\] (1e-05)                                                                                              No
  ORF05932             Type III secretion chaperone CesT family                                YP_595407.1 *Lawsonia intracellularis* PHE/MN1-00 hypothetical protein LI1032 \[Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 3/132 (2%)\] (1e-08)                                                                                                  No
  ORF05933             Type III secretion chaperone CesT family                                YP_961179.1 *Desulfovibrio vulgaris* spp. *vulgaris* DP4 TIR chaperone family protein \[Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 5/111 (4%)\] (3e-07)                                                                                          No
  ORF06015             Type III secretion chaperone CesT family                                YP_434498.1 *Hahella chejuensis* KCTC 2396 hypothetical protein HCH_03318 \[Identities = 35/141 (24%), Positives = 61/141 (43%), Gaps = 7/141 (4%)\] (0.001)                                                                                                      No

###### 

**Results of yeast two-hybrid screening to detect protein:protein interactions between putative needle proteins and putative chaperones**.

  Bait/prey pair                                                    *HIS3* induction   B-Galactosidase induction   Interaction                
  ----------------------------------------------------------------- ------------------ --------------------------- ------------- ---- ------- --------
  pEXP32Krev1/pEXPRalGDS-wt (control strong positive interaction)   \+                 \+                          \+            \+   Blue    Strong
  pEXP32Krev1/pEXPRalGDS-m1 (control weak positive interaction)     \+                 \+                          \+            \+   Blue    Weak
  pEXP32Krev1/pEXPRalGDS-m2 (control negative interaction)          −                  −                           −             −    White   No
  pEXP32VspF1/pEXP22VspF2                                           −                  −                           −             −    White   No
  pEXP32VspF1/pEXP22VspE                                            \+                 \+                          \+            \+   Blue    Strong
  pEXP32VspF1/pEXP22VspG                                            −                  −                           −             −    White   No
  pEXP32VspF2/pEXP22VspF2                                           −                  −                           −             −    White   No
  pEXP32VspF2/pEXP22VspE                                            −                  −                           −             −    White   No
  pEXP32VspF2/pEXP22VspG                                            −                  −                           −             −    White   No

###### 

**Oligonucleotide primers used in this study**.

  Gene product   Open Reading frame   Oligonucleotide primers       Primer binding positions          Primer annealing temp.°C   
  -------------- -------------------- ----------------------------- --------------------------------- -------------------------- ----
  VspC           ORF05910             AAGACCAAGAACACCCGCCAGATA      AAG AAG CGC TGT TTG CGC TCA TTC   1595f-1698r                62
  VspQ           ORF05897             AAGGTGCCTGTGAGGTGCTGATTT      GCG GGA TCG CTC ATG ATG AAT TGT   567f-666r                  62
  VspF1          ORF05908             AGCTCACTGAATATCTCGGCACCT      TTTCAGCCTGATCAATGCTGTGGG          71f-190r                   62
  VspF2          ORF05907             ACGAAGAAACCACCCAGGTGATGA      TGGATCGCTTTCACAAGGTTGGAG          83f-221r                   62
  VspF1          ORF05908             CAC CAT GAC AGA CAT TGA TAC   TCA GTC GTT TTG TTT ATC CCC       17f-235r                   60
  VspF2          ORF05907             CAC CAT GGC AAT TGA CTT TG    CTA ACG AAG GTT GCT GAC AG        16f-239r                   60
  VspG           ORF05906             CAC CAT GAT CCC CGT CGA T     TCA TAG AAA GTT GCG TTT GGG       15f-388r                   60
  VspE           ORF05905             CAC CAT GAG CGT ACC TCT TG    TCA ACC GCC GCG GCT GAG           16f-439r                   60
                 ORF05930             CAC CAT GCA CAA GAT TTC CG    TCA GTC CCC GAT CTT GTC CG        16f-2044r                  58
                 ORF05930             CCATA ATG CAC AAG ATT TCC G   GTC CCC GAT CTT GTC CGA C         16f-2046r                  58
                 ORF01842             CCATA ATG CCT CCT ATT TC      CCT GGG GGA GTC CGG TC            14f-560r                   56
                 ORF04374             CCATA ATG AAT AGC TTC C       CAA GAG GAT GAT CGA TG            13f-1070r                  56
                 ORF03840             CCATA ATG AAA ATC TCT AGC G   GTCCG CGG AGC GCA AAG             16f-662r                   56
                 ORF04373             CCATA ATG ATC GAC GAC TC      GGCGC AGA GAT AGT GCG             14f-434r                   58
                 ORF05921             CCATA ATG CCG ACG GGC         TGA CTC GGA AGT GGC GG            12f-497r                   56

![***Caenorhabditis elegans* survival assays. Each experiment comprised approximately 100 worms**. **(A)** Wild-type worms (N2) exposed to live *V. spinosum* died faster than worms exposed to *E. coli*, according to log-rank analysis (*p* = 3.71 e^−7^), whereas worms exposed to heat-killed *V. spinosum* died no faster than worms exposed to *E. coli* (*p* = 0.319). **(B)** When exposed to *S. aureus*, worm mutants hypersensitive to pathogens (*fshr-1*) died faster than N2 wild-type worms (*p* = 9.66 e^−15^). *fshr-1(ok778)* worms over-expressing wild-type *fshr-1* from a multi-copy transgenic array died more slowly than N2 wild-type worms (*p* = 0.00114). **(C)** When exposed to *E. faecalis*, worm mutants hypersensitive to pathogens (*fshr-1*) died faster than N2 wild-type worms (*p* = 3.69 e^−5^). *fshr-1(ok778)* worms over-expressing wild-type *fshr-1* from a multi-copy transgenic array died more slowly than N2 wild-type worms (*p* = 0.000799). **(D)** When exposed to *E. coli*, there was no difference in the mortality rate between wild-type worms, *fshr-1(ok778)* mutants (*p* = 0.541, relative to wild-type), and *fshr-1(ok778)* mutants over-expressing wild-type *fshr-1* from a transgenic multi-copy array (*p* = 0.169, relative to wild-type).](fmicb-02-00211-a001){#FA1}
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